NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.56
-0.36 (-4.04%)
Mar 10, 2026, 4:00 PM EDT - Market closed

NeoGenomics Revenue

In the year 2025, NeoGenomics had annual revenue of $727.33M with 10.11% growth. NeoGenomics had revenue of $190.17M in the quarter ending December 31, 2025, with 10.56% growth.

Revenue (ttm)
$727.33M
Revenue Growth
+10.11%
P/S Ratio
1.53
Revenue / Employee
$290,933
Employees
2,500
Market Cap
1.11B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025727.33M66.77M10.11%
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020444.45M35.62M8.71%
Dec 31, 2019408.83M132.09M47.73%
Dec 31, 2018276.74M36.49M15.19%
Dec 31, 2017240.25M8.44M3.64%
Dec 31, 2016231.81M132.01M132.27%
Dec 31, 201599.80M12.73M14.62%
Dec 31, 201487.07M20.60M31.00%
Dec 31, 201366.47M6.60M11.02%
Dec 31, 201259.87M16.38M37.68%
Dec 31, 201143.48M9.11M26.51%
Dec 31, 201034.37M4.90M16.63%
Dec 31, 200929.47M9.45M47.23%
Dec 31, 200820.02M8.51M73.97%
Dec 31, 200711.50M5.03M77.65%
Dec 31, 20066.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
Myriad Genetics824.50M
OPKO Health606.88M
Veracyte517.15M
GeneDx Holdings427.54M
Twist Bioscience391.56M
CareDx379.81M
Castle Biosciences344.23M
Revenue Rankings